Cochlear【COH】銘柄情報

Cochlear Limited (COH) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

124.50

( 3.45% )

買値

124.76

売値

124.98

出来高

380,897

121.45 日の範囲 125.07

88.74 52 週間の範囲 319.56

時価総額

8.142B

前日終値

120.35

始値

121.62

時刻

102800

124.96

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 689,502

発行済株式数

65,398,681

配当利回り

4.3 (4.30%)

PER

22.4

1 株当たり利益 (EPS)

5.27

歳入

2.34B

純利益

345.3M

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal ... Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.cochlear.com

本社

Sydney, Australia

設立

1981

Cochlear Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker COH. The last closing price for Cochlear was AUD120.35. Over the last year, Cochlear shares have traded in a share price range of AUD 88.74 to AUD 319.56.

Cochlear currently has 65,398,681 shares in issue. The market capitalisation of Cochlear is AUD8.14 billion. Cochlear has a price to earnings ratio (PE ratio) of 22.40.

Cochlear and GN Hearing Strengthen Technology and Commercial Alliance to Develop Best-in-Class Integrated Hearing Solutions

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, and GN (GN.CO), the global leader in intelligent audio...

Cochlear Brings Leading Hearing Technology to Android Smartphone Users

People with a Nucleus® 7 Sound Processor can now benefit from monitoring and direct control functionality on any compatible Android...

World-Leading Experts Collaborate at Cochlear’s Global Research Symposium

Australia’s world-leading research and clinical facilities based at Macquarie University will be showcased to the international audiology...

Asian Shares Mostly Higher

Australian shares are nearing their highest level since late October on Monday, though falling commodities prices muted gains triggered by...

GN ReSound et Cochlear Limited créent la Smart Hearing Alliance en vue de développer et commercialiser des solutions bimoda...

Les chefs de file du secteur élargissent leur collaboration afin de promouvoir conjointement de nouvelles solutions auditives pour une...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	10.5	9.21052631579	114	125.07	113.74	521603	119.10670699	DE
4	26.86	27.5092175338	97.64	125.07	94.23	589314	111.32915935	DE
12	-50.5	-28.8571428571	175	179.78	88.74	686007	106.67316551	DE
26	-136.5	-52.2988505747	261	278.35	88.74	433278	130.88712271	DE
52	-180.1	-59.1267235719	304.6	319.56	88.74	275603	166.99959375	DE
156	-104.29	-45.5832859828	228.79	350.31	88.74	191568	229.6859163	DE
260	-122.12	-49.5174762793	246.62	350.31	88.74	171186	226.3614213	DE